Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus

S. B. Greenberg, M. W. Harmon, R. B. Couch, P. E. Johnson, S. Z. Wilson, C. C. Dacso, K. Bloom, J. Quarles

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The prophylactic effect of low doses of human leukocyte interferon (HuIFN-a) against infection with rhinovirus was measured in double-blind, placebo-controlled studies with volunteer subjects. An antihistamine (chlorpheniramine) was given before administration of single or multiple doses of HuIFN-a by saturated cotton pledget or by aerosol; volunteers were then challenged with rhinovirus. When the results for all groups were combined, a lower frequency of respiratory illness was demonstrated in the HuIFNa-treated volunteers (20 of 39 vs. 11 of 38, P <0.05). A significant improvement in mean symptom scores was found only in the volunteers who received HuIFN-a by cotton pledget. The total numbers of isolates of rhinovirus and seroconversions were similar for HuIFN-a-treated and control volunteers. No significant side effects were noted in the HuIFN-a-treated volunteers. Higher concentrations or improved methods of delivery of HuIFN-a will be necessary for improving the clinical efficacy of HuIFN-a against viral infections in the respiratory system.

Original languageEnglish (US)
Pages (from-to)542-546
Number of pages5
JournalJournal of Infectious Diseases
Volume145
Issue number4
DOIs
StatePublished - 1982
Externally publishedYes

Fingerprint

Rhinovirus
Interferon-alpha
Volunteers
Infection
Chlorpheniramine
Histamine Antagonists
Virus Diseases
Aerosols
Respiratory System
Placebos

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Greenberg, S. B., Harmon, M. W., Couch, R. B., Johnson, P. E., Wilson, S. Z., Dacso, C. C., ... Quarles, J. (1982). Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus. Journal of Infectious Diseases, 145(4), 542-546. https://doi.org/10.1093/infdis/145.4.542

Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus. / Greenberg, S. B.; Harmon, M. W.; Couch, R. B.; Johnson, P. E.; Wilson, S. Z.; Dacso, C. C.; Bloom, K.; Quarles, J.

In: Journal of Infectious Diseases, Vol. 145, No. 4, 1982, p. 542-546.

Research output: Contribution to journalArticle

Greenberg, SB, Harmon, MW, Couch, RB, Johnson, PE, Wilson, SZ, Dacso, CC, Bloom, K & Quarles, J 1982, 'Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus', Journal of Infectious Diseases, vol. 145, no. 4, pp. 542-546. https://doi.org/10.1093/infdis/145.4.542
Greenberg, S. B. ; Harmon, M. W. ; Couch, R. B. ; Johnson, P. E. ; Wilson, S. Z. ; Dacso, C. C. ; Bloom, K. ; Quarles, J. / Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus. In: Journal of Infectious Diseases. 1982 ; Vol. 145, No. 4. pp. 542-546.
@article{4901d18036b34c7b87ab28cabc480b3e,
title = "Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus",
abstract = "The prophylactic effect of low doses of human leukocyte interferon (HuIFN-a) against infection with rhinovirus was measured in double-blind, placebo-controlled studies with volunteer subjects. An antihistamine (chlorpheniramine) was given before administration of single or multiple doses of HuIFN-a by saturated cotton pledget or by aerosol; volunteers were then challenged with rhinovirus. When the results for all groups were combined, a lower frequency of respiratory illness was demonstrated in the HuIFNa-treated volunteers (20 of 39 vs. 11 of 38, P <0.05). A significant improvement in mean symptom scores was found only in the volunteers who received HuIFN-a by cotton pledget. The total numbers of isolates of rhinovirus and seroconversions were similar for HuIFN-a-treated and control volunteers. No significant side effects were noted in the HuIFN-a-treated volunteers. Higher concentrations or improved methods of delivery of HuIFN-a will be necessary for improving the clinical efficacy of HuIFN-a against viral infections in the respiratory system.",
author = "Greenberg, {S. B.} and Harmon, {M. W.} and Couch, {R. B.} and Johnson, {P. E.} and Wilson, {S. Z.} and Dacso, {C. C.} and K. Bloom and J. Quarles",
year = "1982",
doi = "10.1093/infdis/145.4.542",
language = "English (US)",
volume = "145",
pages = "542--546",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus

AU - Greenberg, S. B.

AU - Harmon, M. W.

AU - Couch, R. B.

AU - Johnson, P. E.

AU - Wilson, S. Z.

AU - Dacso, C. C.

AU - Bloom, K.

AU - Quarles, J.

PY - 1982

Y1 - 1982

N2 - The prophylactic effect of low doses of human leukocyte interferon (HuIFN-a) against infection with rhinovirus was measured in double-blind, placebo-controlled studies with volunteer subjects. An antihistamine (chlorpheniramine) was given before administration of single or multiple doses of HuIFN-a by saturated cotton pledget or by aerosol; volunteers were then challenged with rhinovirus. When the results for all groups were combined, a lower frequency of respiratory illness was demonstrated in the HuIFNa-treated volunteers (20 of 39 vs. 11 of 38, P <0.05). A significant improvement in mean symptom scores was found only in the volunteers who received HuIFN-a by cotton pledget. The total numbers of isolates of rhinovirus and seroconversions were similar for HuIFN-a-treated and control volunteers. No significant side effects were noted in the HuIFN-a-treated volunteers. Higher concentrations or improved methods of delivery of HuIFN-a will be necessary for improving the clinical efficacy of HuIFN-a against viral infections in the respiratory system.

AB - The prophylactic effect of low doses of human leukocyte interferon (HuIFN-a) against infection with rhinovirus was measured in double-blind, placebo-controlled studies with volunteer subjects. An antihistamine (chlorpheniramine) was given before administration of single or multiple doses of HuIFN-a by saturated cotton pledget or by aerosol; volunteers were then challenged with rhinovirus. When the results for all groups were combined, a lower frequency of respiratory illness was demonstrated in the HuIFNa-treated volunteers (20 of 39 vs. 11 of 38, P <0.05). A significant improvement in mean symptom scores was found only in the volunteers who received HuIFN-a by cotton pledget. The total numbers of isolates of rhinovirus and seroconversions were similar for HuIFN-a-treated and control volunteers. No significant side effects were noted in the HuIFN-a-treated volunteers. Higher concentrations or improved methods of delivery of HuIFN-a will be necessary for improving the clinical efficacy of HuIFN-a against viral infections in the respiratory system.

UR - http://www.scopus.com/inward/record.url?scp=0020078959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020078959&partnerID=8YFLogxK

U2 - 10.1093/infdis/145.4.542

DO - 10.1093/infdis/145.4.542

M3 - Article

C2 - 6175705

AN - SCOPUS:0020078959

VL - 145

SP - 542

EP - 546

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -